Evidence. Excellence. Education.
Longevity Evidence Review Service
BILM’s Evidence Review Service provides independent, clinically rigorous review of longevity medicine, preventive medicine and regenerative health interventions, products and claims. It is designed for clinics, companies, investors and organisations that want a clear, credible assessment of the evidence behind a service or product.
What we review
Our focus is on whether the evidence supports the claimed use, whether the product or service is clinically plausible, and whether it can be positioned responsibly and ethically.
We can assess a wide range of longevity-related interventions and commercial propositions, including:
- Supplements and nutraceuticals.
- Diagnostics and biomarker panels.
- Regenerative or anti-ageing therapies.
- Longevity clinic programmes.
- Health optimisation protocols.
- Digital health tools.
- Evidence claims made in marketing materials or investor decks.
- Medical devices and wearables.
What the review includes
Where useful, we can also provide a more detailed report with evidence grading, summary tables and recommendations for next steps.
Each review is tailored to the brief, but may include:
Assessment of study quality and strength of evidence.
A structured literature review.
Review of mechanism of action and biological plausibility.
Safety and risk appraisal.
Comparison with current best practice and standard care.
Evaluation of patient selection and intended use.
Practical commercial and clinical considerations.
Analysis of claims, limitations and uncertainties.
Who this is for
Our Evidence Review Service is ideal for:
Longevity clinics seeking to validate a new service or protocol.
Supplement brands wanting an independent review of their product claims.
Medtech and digital health companies entering the longevity market.
Investors and innovators assessing commercial opportunity and scientific credibility.
Healthcare organisations exploring whether a longevity intervention is worth adopting.
Why it matters
The longevity sector is growing quickly, but not every claim is backed by strong evidence. BILM helps separate promising innovation from unsupported marketing by applying a professional, evidence-based lens.
This can help you:
Strengthen credibility with clinicians and customers.
Identify risks, gaps and unsupported claims early.
Improve product positioning and messaging.
Support regulatory, clinical or commercial decision-making.
Build trust through transparency and scientific discipline.
Our Approach
We aim to be balanced, independent and practical. That means we do not simply ask whether something sounds exciting; we ask whether it is supported by the evidence, appropriate for the intended population and safe to recommend in real-world practice.
Where the evidence is strong, we will say so. Where it is weak, uncertain or speculative, we will say that too.
Enquiries
If you would like BILM to review a product, service or claim, please contact us with a brief outline of the project and the type of review required.